The role of the healthcare supply chain is rapidly evolving and increasingly important within the healthcare ecosystem, due in large part to the COVID-19 pandemic. The public health crisis also helped expose multiple supply chain vulnerabilities that presents new challenges and demands innovation.
As a leader in global strategy consulting serving clients across the healthcare spectrum, L.E.K. operates a healthcare supply chain practice focused on several key segments of the supply chain that are becoming increasingly critical as care delivery continues to evolve (where, how, and who delivers care). We have deep experience helping clients in these segments grapple with strategic questions, both the challenges and the opportunities market changes present.
Many of these organizations have had to evolve their offerings, business models and commercial approaches significantly as healthcare has changed in the last decade, but especially in the face of the pandemic. We have helped our healthcare supply chain clients overcome significant strategic challenges and uncover areas where they can capitalize on growth opportunities.
How We Help
L.E.K. has completed case work for leaders across the ecosystem and has worked closely with the investor community. Here are just a few examples of our work within the healthcare supply chain:
Solutions portfolio strategy for a leading healthcare distributor to better serve acute and ambulatory surgery center (ASC) customers with service and data solutions focused on inventory management and clinical and non-clinical workflow support
Adjacency growth strategy for a leading healthcare supply chain technology and services company, yielding a clear and prioritized roadmap for both organic and inorganic opportunities
Go-to-market strategy support for a large specialty distributor seeking to expand its presence in healthcare, including customer segmentation, prioritization, account targeting, and organizational capability building
Growth strategy roadmap for a group purchasing organization (GPO) seeking to evolve its competitive position and bolster its value proposition to provider members
Strategic growth and EBITDA enhancement roadmap for a major home infusion and pharmacy player
New product development assessment support and broader strategy roadmap for a leading 503b outsourced compounding pharmacy
Numerous buy-side and sell-side commercial due diligences across healthcare supply chain, including many DME and home healthcare distribution businesses (e.g., diabetes, incontinence, wound care, respiratory / oxygen, sleep apnea, traditional DME)